Expression of MRP and mdr1 in human gastrointestinal cancer cell lines: a correlation with resistance against doxorubicin

J Surg Oncol. 1996 Mar;61(3):223-9. doi: 10.1002/(SICI)1096-9098(199603)61:3<223::AID-JSO12>3.0.CO;2-8.

Abstract

The mRNA expression of mdr1 and MRP, each of which codes for a transport protein belonging to ATP-binding cassette superfamily and are reported to be responsible for multidrug resistance phenotype, were semi-quantified by RT-PCR in a panel of gastrointestinal cancer cell lines. Although the expression of MRP was predominant in esophageal cancer cell lines, expression of either or both of the genes was detected in all the cell lines tested. Expression of these two genes added together correlated significantly with chemosensitivity against doxorubicin, implicating that expression of both genes should be evaluated in the future analysis of multidrug resistance phenotype. The ID50 values for pirarubicin, although generally lower than the values for doxorubicin, correlated well with the latter, suggesting that the similar phenotype as that for doxorubicin might be responsible for drug resistance against this semisynthetic anthracycline glycoside.

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics*
  • ATP-Binding Cassette Transporters / genetics*
  • Antibiotics, Antineoplastic*
  • Doxorubicin* / analogs & derivatives
  • Drug Resistance, Neoplasm / genetics*
  • Gastrointestinal Neoplasms / genetics*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Multidrug Resistance-Associated Proteins
  • Neoplasm Proteins / genetics*
  • Oncogenes / genetics
  • Phenotype
  • Polymerase Chain Reaction
  • RNA, Messenger / genetics
  • Transcription, Genetic
  • Tumor Cells, Cultured

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • ATP-Binding Cassette Transporters
  • Antibiotics, Antineoplastic
  • Multidrug Resistance-Associated Proteins
  • Neoplasm Proteins
  • RNA, Messenger
  • Doxorubicin
  • pirarubicin